AIDS vaccines, immunology, and what we have learned.
作者信息
Laurence Jeffrey
出版信息
AIDS Read. 2002 Aug;12(8):338, 343.
PMID:12229890
Abstract
摘要
相似文献
1
AIDS vaccines, immunology, and what we have learned.
AIDS Read. 2002 Aug;12(8):338, 343.
2
Role of cellular immunity in protection against HIV infection.细胞免疫在预防HIV感染中的作用。
Adv Immunol. 1997;65:277-346.
3
Public health. A sound rationale needed for phase III HIV-1 vaccine trials.公共卫生。HIV-1疫苗三期试验需要合理依据。
Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620.
4
Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.旨在实现成功的疫苗诱导的HIV-1特异性细胞毒性T淋巴细胞。
AIDS. 2008 Jan 30;22(3):325-31. doi: 10.1097/QAD.0b013e3282f29491.
5
Development of prophylactic AIDS vaccines: the current state of affairs.预防性艾滋病疫苗的研发：现状
Curr Opin Mol Ther. 2003 Feb;5(1):25-32.
6
Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?迈向开发用于治疗HIV-1感染的治疗性疫苗：我们比以往任何时候都更接近了吗？
Expert Rev Vaccines. 2007 Jun;6(3):289-91. doi: 10.1586/14760584.6.3.289.
7
CTL ontogeny and viral escape: implications for HIV-1 vaccine design.细胞毒性T淋巴细胞的个体发生与病毒逃逸：对HIV-1疫苗设计的启示
Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004.
8
Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?预测细胞毒性T淋巴细胞HIV疫苗的潜在影响：疫苗接种频率应为多少以及疫苗强度应为多强？
Math Biosci. 2008 Apr;212(2):180-7. doi: 10.1016/j.mbs.2008.02.001. Epub 2008 Feb 20.
9
[HIV vaccination].[艾滋病毒疫苗接种]
MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:68-9.
10
AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.艾滋病/艾滋病毒。开发艾滋病疫苗：需求、不确定性与希望。
Science. 2004 Jun 25;304(5679):1913-4. doi: 10.1126/science.1100368.
Zotero 插件